arsenic trisulfide has been researched along with Colonic Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; Kang, T; Tan, Z; Zhang, L; Zhang, X | 1 |
| Chen, S; Pan, M; Tong, Y; Zhang, L; Zhang, X | 1 |
| Chen, S; Ding, W; Pan, M; Tong, Y; Zhang, X | 1 |
3 other study(ies) available for arsenic trisulfide and Colonic Neoplasms
| Article | Year |
|---|---|
Arsenic sulfide amplifies JQ1 toxicity via mitochondrial pathway in gastric and colon cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Arsenicals; Azepines; Cell Proliferation; Colonic Neoplasms; Drug Screening Assays, Antitumor; Humans; Membrane Potentials; Mitochondria; Stomach Neoplasms; Sulfides; Triazoles; Tumor Cells, Cultured | 2018 |
Arsenic sulfide combined with JQ1, chemotherapy agents, or celecoxib inhibit gastric and colon cancer cell growth.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenicals; Azepines; Camptothecin; Celecoxib; Cell Line, Tumor; Cisplatin; Colonic Neoplasms; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Irinotecan; p38 Mitogen-Activated Protein Kinases; Stomach Neoplasms; Sulfides; Triazoles; Tumor Suppressor Protein p53 | 2015 |
Study of Arsenic Sulfide in Solid Tumor Cells Reveals Regulation of Nuclear Factors of Activated T-cells by PML and p53.
Topics: Arsenicals; Cell Death; Cell Proliferation; Cell Survival; Colonic Neoplasms; Cyclosporine; Down-Regulation; Drug Synergism; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; HCT116 Cells; Humans; Models, Biological; NFATC Transcription Factors; Promoter Regions, Genetic; Promyelocytic Leukemia Protein; Proto-Oncogene Proteins c-myc; RNA, Messenger; Sulfides; Transcription, Genetic; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2016 |